A Phase 1 First-in-Human Study of Tnb-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Patients with Relapsed/Refractory Multiple Myeloma
暂无分享,去创建一个
R. Vij | Shaji K. Kumar | P. Voorhees | K. Freise | A. D’Souza | B. Buelow | N. Shah | Akshanth R. Polepally | S. Yue | C. Rodriguez | Orlando F. Bueno | R. K. Pothacamury